← Open Payments lookup

REBECCA MOONEY: Open Payments

NPI 1154323319 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,174 in 186 payments from 23 companies in 2025. Trend: 2023 $2,632 · 2024 $3,649 · 2025 $4,174

Food & beverage: $4,074Education: $100
CompanyPaymentsAmount
ABBVIE INC.43$746
Janssen Biotech, Inc.23$717
Salix Pharmaceuticals, a division of Bausch Health US, LLC20$498
Madrigal Pharmaceuticals18$399
Takeda Pharmaceuticals U.S.A., Inc.14$355
GENZYME CORPORATION11$302
Ipsen Biopharmaceuticals, Inc6$179
Phathom Pharmaceuticals, Inc.10$178
Gilead Sciences, Inc.10$165
PFIZER INC.6$117

Products named: TREMFYA, XIFAXAN, DUPIXENT, REZDIFFRA, CREON, ENTYVIO, IQIRVO, SKYRIZI.

Industry payments across MD — which companies pay providers there.